Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PISCES-II: CTX0E03 DP in Ischaemic Stroke
NCT02117635Phase 2Completed
- Sponsor
- ReNeuron
- Start
- Jun 2014
- Primary completion
- Oct 2016
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of CTX0E03 DP in ischemic stroke, sponsored by ReNeuron. Started Jun 2014; status: completed.
02
Drugs
CTX0E03 DP
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02117635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117635.